Center Laboratories, Inc. (TPEX:4123)

Center Laboratories Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,442	1,705	796.74	267.46	923.38
Short-Term Investments	350.01	745.52	522.07	-	-
Trading Asset Securities	258	973.87	1,029	4,582	232.71
Cash & Short-Term Investments	2,050	3,424	2,348	4,849	1,156
Cash Growth	-40.12%	45.83%	-51.58%	319.43%	22.10%
Accounts Receivable	202.69	244.61	174.35	114.78	127.08
Other Receivables	-	-	14.52	457.93	22.11
Receivables	202.69	244.61	188.87	572.71	149.19
Inventory	309.7	269.23	89.31	100.64	108.26
Other Current Assets	1,219	1,184	225.25	5,371	21.43
Total Current Assets	3,782	5,121	2,851	10,893	1,435
Property, Plant & Equipment	1,433	1,371	532.8	743.04	763.73
Long-Term Investments	13,838	15,147	14,387	11,578	15,882
Goodwill	398.36	398.36	1.35	-	-
Other Intangible Assets	381.99	427.48	1.94	3.13	4.69
Long-Term Accounts Receivable	-	-	-	-	21.15
Long-Term Deferred Tax Assets	32.51	11.22	-	-	-
Other Long-Term Assets	5,672	4,526	7,413	7,227	9,761
Total Assets	25,537	27,002	25,188	30,444	27,867
Accounts Payable	134.79	144.64	100.56	30.31	63.49
Accrued Expenses	142.28	139.89	440.36	89.15	147.47
Short-Term Debt	1,262	330	310	1,252	2,217
Current Portion of Long-Term Debt	2,596	852.89	1,869	433.33	1
Current Portion of Leases	9.21	9.44	0.35	0.54	1.27
Current Income Taxes Payable	277.33	211.34	953.24	267.15	221.91
Current Unearned Revenue	159.25	113.67	84.07	113.51	97.28
Other Current Liabilities	36.08	43.21	165.91	494.59	8.05
Total Current Liabilities	4,617	1,845	3,923	2,680	2,757
Long-Term Debt	2,655	4,412	1,289	3,676	1,777
Long-Term Leases	8.17	17.13	-	0.09	0.63
Long-Term Unearned Revenue	4.84	-	-	-	-
Long-Term Deferred Tax Liabilities	148.74	434.02	717.74	2,113	2,015
Other Long-Term Liabilities	49.26	77.81	5.3	879.67	682.62
Total Liabilities	7,483	6,786	5,935	9,349	7,233
Common Stock	7,250	6,914	5,948	5,050	4,593
Additional Paid-In Capital	5,536	7,242	5,553	4,556	4,512
Retained Earnings	5,460	5,823	7,754	9,680	9,057
Treasury Stock	-209.65	-246.72	-	-	-86.79
Comprehensive Income & Other	18.86	24.42	-2.14	-347.79	-93.17
Total Common Equity	18,054	19,757	19,252	18,939	17,981
Minority Interest	0.01	459.35	-	2,156	2,653
Shareholders' Equity	18,054	20,216	19,252	21,095	20,634
Total Liabilities & Equity	25,537	27,002	25,188	30,444	27,867
Total Debt	6,530	5,621	3,468	5,362	3,997
Net Cash (Debt)	-4,480	-2,197	-1,120	-512.52	-2,841
Net Cash Per Share	-6.31	-3.31	-1.74	-0.77	-4.43
Filing Date Shares Outstanding	720.42	686.06	653.74	636.17	634.36
Total Common Shares Outstanding	720.42	686.06	653.74	636.17	634.36
Working Capital	-835.26	3,276	-1,072	8,213	-1,322
Book Value Per Share	25.06	28.80	29.45	29.77	28.35
Tangible Book Value	17,274	18,931	19,249	18,936	17,977
Tangible Book Value Per Share	23.98	27.59	29.44	29.77	28.34
Land	1,017	997.95	591.88	782.99	779.59
Machinery	970.49	872.53	272.06	264.47	261.73
Construction In Progress	76.77	46.26	-	2.78	2.49
Leasehold Improvements	137.86	129.66	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.